Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

WHAT'S NEW

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Sep 16 2016

Full Issue

Mass. Tweaks Marijuana Rules, Incorporating Lessons Learned From First 3 Years

Granting more power to nurse practitioners to decide if a patient should be given medical marijuana and stricter labeling of the products are among the handful of updated regulations. In other news, a judge in Florida says officials there broke their own rules when granting marijuana licenses and legalization supporters in Massachusetts net a big-name donor. Meanwhile, scientists wonder, does marijuana make us lazy?

WBUR: State Health Agency Offers Overhaul Of Medical Marijuana Regulations

Nurse practitioners would be allowed to certify patients for medical marijuana and dispensaries would be allowed to post product prices on their websites, under new regulations proposed by the Department of Public Health. The changes, according to state health officials, build off of lessons learned during the first three years of experience with medical marijuana in Massachusetts. (Lannan, 9/15)

Health News Florida: Judge Blasts Health Officials Over Pot Scorecards 

Saying they did not follow their own rules, an administrative law judge scalded state health officials for the method used to grant highly coveted medical-marijuana licenses to nurseries last fall. Administrative Law Judge John Van Laningham also made clear that he intends to recommend that the Department of Health issue another "dispensing organization" license because Alpha Foliage --- already distributing medical marijuana --- did not meet the legal criteria for the license it received in November. (Kam, 9/15)

Boston Globe: Athenahealth’s Jonathan Bush Donates To Marijuana Legalization Effort 

Marijuana legalization proponents in Massachusetts can count Jonathan Bush, the CEO of Watertown-based health care company Athenahealth and a cousin of former President George W. Bush, in their corner. According to state political finance records, Bush donated $10,000 to the Yes on 4 campaign, which seeks to legalize the use and sale of recreational marijuana in the state through a ballot initiative this November. (Vaccaro, 9/15)

The Washington Post: New Study Finds That Medical Marijuana May Be Helping To Curb The Opioid Epidemic

Researchers analyzed federal crash data in 18 states over the period from 1999 to 2013. States that passed a medical marijuana law during this period saw a reduction in opioid involvement in fatal car accidents, relative to states without such a law. The reduction was greatest among drivers aged 21 to 40, the age group most likely to use medical marijuana where it's available. (Ingraham, 9/15)

The Wall Street Journal: Marijuana Makes For Slackers? Now There’s Evidence

In street marijuana, the THC-to-CBD ratio now tends to be 10 to 1, and it is increasing, a trend occurring even at some marijuana clinics, Dr. Winstanley said. And few people know what effect that has on their brains. A new study by Dr. Winstanley’s group in the Journal of Psychiatry and Neuroscience examines how these two chemicals shape our willingness to face a challenge. Does marijuana make us lazy? (Pinker, 9/15)

The Washington Post: The DEA Wants To Ban Another Plant. Researchers Say The Plan Is ‘Insane.’

The Drug Enforcement Administration has received a torrent of backlash from patients with chronic pain and former opiate users after announcing plans to ban kratom, a plant gaining popularity across the United States for its opiate-like effects. Kratom, which originates in Southeast Asia, has become more widespread in the United States in the past decade, fueled by online testimonials from users and a lack of federal regulation. Advocates say the plant — typically crushed and mixed or brewed with water — poses few health risks while helping users relieve severe pain and overcome addictions to powerful prescription painkillers. (Ingraham, 9/15)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 22
  • Thursday, May 21
  • Wednesday, May 20
  • Tuesday, May 19
  • Monday, May 18
  • Friday, May 15
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF